Lysoway Therapeutics
PrivateLast Round
Grant
Jun 1, 2026
Total Funding Raised
$28.33M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lysoway Therapeutics is a biopharmaceutical company that develops small-molecule modulators of lysosomal ion channels to treat neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysoway Therapeutics Comparables
Compare Lysoway Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libra Therapeutics | 86% | |
| Casma Therapeutics | 85% | |
| Tenvie Therapeutics | 80% |
Lysoway Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2026 | ||||
| Grant | Aug 5, 2025 | ||||
| Grant | Jan 5, 2023 | ||||
| Series A | Oct 5, 2022 |
Key People
Founding team and executive leadership
Lysoway Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| Highlight Capital | Series A |
| Bencao Capital | Series A |
| Oceanpine Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| The Silverstein Foundation for Parkinson's with GBA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 38% MoM, reaching 1.5K.
- Jun 1, 2026
Received $3M from The Michael J. Fox Foundation.
Lysoway Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lysoway Therapeutics's valuation, stock price, and market status.
Is Lysoway Therapeutics a public or private company?
Lysoway Therapeutics is a private company.
What is the current stock price of Lysoway Therapeutics?
Lysoway Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Lysoway Therapeutics worth (valuation)?
Valuation information for Lysoway Therapeutics is not publicly available.
Can I buy Lysoway Therapeutics stock?
Lysoway Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lysoway Therapeutics's last funding round?
Lysoway Therapeutics's most recent funding round was Grant on August 5, 2025.
Who are the main investors in Lysoway Therapeutics?
Key investors in Lysoway Therapeutics include HighLight Capital, Bencao Capital, Oceanpine Capital.
Will Lysoway Therapeutics IPO soon?
No public IPO plans have been announced for Lysoway Therapeutics.
How can I track Lysoway Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lysoway Therapeutics's secondary market activity and sign up for updates.